相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。An antimicrobial helix A-derived peptide of heparin cofactor II blocks endotoxin responses in vivo
Praveen Papareddy et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2014)
Importance of lipopolysaccharide aggregate disruption for the anti-endotoxic effects of heparin cofactor II peptides
Shalini Singh et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2013)
Biomarkers of sepsis
James D. Faix
CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES (2013)
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock, 2012
R. P. Dellinger et al.
INTENSIVE CARE MEDICINE (2013)
Proteolytic Activation Transforms Heparin Cofactor II into a Host Defense Molecule
Martina Kalle et al.
JOURNAL OF IMMUNOLOGY (2013)
Antimicrobial peptides stage a comeback
Jeffrey L. Fox
NATURE BIOTECHNOLOGY (2013)
Severe Sepsis and Septic Shock REPLY
Derek C. Angus et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Severe Sepsis and Septic Shock
Derek C. Angus et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
A comprehensive summary of LL-37, the factotum human cathelicidin peptide
Dieter Vandamme et al.
CELLULAR IMMUNOLOGY (2012)
Antimicrobial peptides: key components of the innate immune system
Mukesh Pasupuleti et al.
CRITICAL REVIEWS IN BIOTECHNOLOGY (2012)
Host Defense Peptides of Thrombin Modulate Inflammation and Coagulation in Endotoxin-Mediated Shock and Pseudomonas aeruginosa Sepsis
Martina Kalle et al.
PLOS ONE (2012)
Antimicrobial peptides and their potential application in inflammation and sepsis
Tobias Schuerholz et al.
CRITICAL CARE (2012)
Structure-Activity Studies and Therapeutic Potential of Host Defense Peptides of Human Thrombin
Gopinath Kasetty et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Thymic stromal lymphopoietin exerts antimicrobial activities
Andreas Sonesson et al.
EXPERIMENTAL DERMATOLOGY (2011)
The C-Terminal Sequence of Several Human Serine Proteases Encodes Host Defense Functions
Gopinath Kasetty et al.
JOURNAL OF INNATE IMMUNITY (2011)
Recombinant human tissue factor pathway inhibitor exerts anticoagulant, anti-inflammatory and antimicrobial effects in murine pneumococcal pneumonia
F. E. van den Boogaard et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2011)
Inflammation and coagulation
Marcel Levi et al.
CRITICAL CARE MEDICINE (2010)
The continuing crisis in antibiotic resistance
G. L. French
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2010)
C-terminal Peptides of Tissue Factor Pathway Inhibitor Are Novel Host Defense Molecules
Praveen Papareddy et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Synthetic Cationic Peptide IDR-1002 Provides Protection against Bacterial Infections through Chemokine Induction and Enhanced Leukocyte Recruitment
Anastasia Nijnik et al.
JOURNAL OF IMMUNOLOGY (2010)
The Systemic Pro-Inflammatory Response in Sepsis
Hanna Katrien de Jong et al.
JOURNAL OF INNATE IMMUNITY (2010)
Contact system activation in severe infectious diseases
Sonja Oehmcke et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2010)
Proteolysis of Human Thrombin Generates Novel Host Defense Peptides
Praveen Papareddy et al.
PLOS PATHOGENS (2010)
International Study of the Prevalence and Outcomes of Infection in Intensive Care Units
Jean-Louis Vincent et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
AMPed up immunity: how antimicrobial peptides have multiple roles in immune defense
Yuping Lai et al.
TRENDS IN IMMUNOLOGY (2009)
A clinical evaluation committee assessment of recombinant human tissue factor pathway inhibitor (tifacogin) in patients with severe community-acquired pneumonia
Pierre-Francois Laterre et al.
CRITICAL CARE (2009)
Rational design of antimicrobial C3a analogues with enhanced effects against staphylococci using an integrated structure and function-based approach
Mukesh Pasupuleti et al.
BIOCHEMISTRY (2008)
Antimicrobial resistance in Europe and its potential impact on empirical therapy
G. M. Rossolini et al.
CLINICAL MICROBIOLOGY AND INFECTION (2008)
Antimicrobial activity of omiganan pentahydrochloride tested against contemporary bacterial pathogens commonly responsible for catheter-associated infections
Thomas R. Fritsche et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances
Irith Wiegand et al.
NATURE PROTOCOLS (2008)
Therapeutic effects of TAK-242, a novel selective Toll-like receptor 4 signal transduction inhibitor, in mouse endotoxin shock model
Takukyu Sha et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2007)
Role of the innate immune system in host defence against bacterial infections: focus on the Toll-like receptors
B. Albiger et al.
JOURNAL OF INTERNAL MEDICINE (2007)
Cytokine profiles as markers of disease severity in sepsis: a multiplex analysis
Fernando A. Bozza et al.
CRITICAL CARE (2007)
Structural biology of the LPS recognition
Roman Jerala
INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY (2007)
Human antimicrobial proteins - effectors of innate immunity
Juergen Harder et al.
JOURNAL OF ENDOTOXIN RESEARCH (2007)
Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies
Robert E. W. Hancock et al.
NATURE BIOTECHNOLOGY (2006)
Modulation of the TLR-mediated inflammatory response by the endogenous human host defense peptide LL-37
N Mookherjee et al.
JOURNAL OF IMMUNOLOGY (2006)
High-dose antithrombin III in the treatment of severe sepsis in patients with a high risk of death: Efficacy and safety
CJ Wiedermann et al.
CRITICAL CARE MEDICINE (2006)
Sepsis in European intensive care units: Results of the SOAP study
JL Vincent et al.
CRITICAL CARE MEDICINE (2006)
Impact of LL-37 on anti-infective immunity
DME Bowdish et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2005)
Dynamic evolution of coagulopathy in the first day of severe sepsis: Relationship with mortality and organ failure
JF Dhainaut et al.
CRITICAL CARE MEDICINE (2005)
Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis -: A randomized controlled trial
E Abraham et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
The epidemiology of sepsis in the United States from 1979 through 2000
GS Martin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Antimicrobial peptides of multicellular organisms
M Zasloff
NATURE (2002)
Assessment of the safety of recombinant tissue factor pathway inhibitor in patients with severe sepsis: A multicenter, randomized, placebo-controlled, single-blind, dose escalation study
E Abraham et al.
CRITICAL CARE MEDICINE (2001)
分享论文
